{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:42:53Z","timestamp":1769006573145,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10067-013-2441-x","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T02:55:29Z","timestamp":1386557729000},"page":"499-503","source":"Crossref","is-referenced-by-count":21,"title":["Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"33","author":[{"given":"Dongying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"2441_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-99-1-1","volume":"99","author":"S Carette","year":"1983","unstructured":"Carette S, Klippel JH, Decker JL et al (1983) Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. Ann Intern Med 99:1\u20138","journal-title":"Ann Intern Med"},{"key":"2441_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"2441_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.47.6.503","volume":"47","author":"ME Jeurissen","year":"1988","unstructured":"Jeurissen ME, Boerbooms AM, van de Putte LB (1988) Pancytopenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 47:503\u2013505","journal-title":"Ann Rheum Dis"},{"key":"2441_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.revmed.2010.09.006","volume":"32","author":"S Ngo","year":"2011","unstructured":"Ngo S, Sauvetre G, Vittecoq O, Levesque H, Marie I (2011) Azathioprine-associated severe myelosuppression: indication of routine determination of thiopurine S-methyltransferase variant? Rev Med Interne 32:373\u2013376","journal-title":"Rev Med Interne"},{"key":"2441_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0961203307085255","volume":"17","author":"U Boonsrirat","year":"2008","unstructured":"Boonsrirat U, Angsuthum S, Vannaprasaht S et al (2008) Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Lupus 17:132\u2013134","journal-title":"Lupus"},{"key":"2441_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","volume":"62","author":"D Otterness","year":"1997","unstructured":"Otterness D, Szumlanski C, Lennard L et al (1997) Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62:60\u201373","journal-title":"Clin Pharmacol Ther"},{"key":"2441_CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamadermatol.2013.137","volume":"149","author":"N Cyrus","year":"2013","unstructured":"Cyrus N, Stavert R, Mason AR, Ko CJ, Choi JN (2013) Neutrophilic dermatosis after azathioprine exposure. JAMA Dermatol 149:592\u2013597","journal-title":"JAMA Dermatol"},{"key":"2441_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0091270011435989","volume":"53","author":"L Colleoni","year":"2013","unstructured":"Colleoni L, Kapetis D, Maggi L et al (2013) A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine. J Clin Pharmacol 53:67\u201374","journal-title":"J Clin Pharmacol"},{"key":"2441_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejim.2011.12.002","volume":"23","author":"T Larussa","year":"2012","unstructured":"Larussa T, Suraci E, Lentini M et al (2012) High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. Eur J Intern Med 23:273\u2013277","journal-title":"Eur J Intern Med"},{"key":"2441_CR10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2007.03301.x","volume":"25","author":"JW Winter","year":"2007","unstructured":"Winter JW, Gaffney D, Shapiro D et al (2007) Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 25:1069\u20131077","journal-title":"Aliment Pharmacol Ther"},{"key":"2441_CR11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1157\/13086124","volume":"126","author":"H Corominas","year":"2006","unstructured":"Corominas H, Domenech M, del R\u00edo E, Gich I, Domingo P, Baiget M (2006) Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain. Med Clin (Barc) 126:410\u2013412","journal-title":"Med Clin (Barc)"},{"key":"2441_CR12","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1248\/bpb.28.2117","volume":"28","author":"Y Okada","year":"2005","unstructured":"Okada Y, Nakamura K, Kodama T et al (2005) Thiopurine methyltransferase genotype and phenotype status in Japanese patients with systemic lupus erythematosus. Biol Pharm Bull 28:2117\u20132119","journal-title":"Biol Pharm Bull"},{"key":"2441_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1472-8206.2009.00770.x","volume":"24","author":"H Xiong","year":"2010","unstructured":"Xiong H, Xin HW, Wu XC, Li Q, Xiong L, Yu AR (2010) Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients. Fundam Clin Pharmacol 24:393\u2013400","journal-title":"Fundam Clin Pharmacol"},{"key":"2441_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/FTD.0b013e3182731925","volume":"34","author":"Z Fangbin","year":"2012","unstructured":"Fangbin Z, Xiang G, Minhu C et al (2012) Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease. Ther Drug Monit 34:695\u2013701","journal-title":"Ther Drug Monit"},{"key":"2441_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2125.2004.02113.x","volume":"58","author":"JP Zhang","year":"2004","unstructured":"Zhang JP, Guan YY, Wu JH, Xu AL, Zhou S, Huang M (2004) Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. Br J Clin Pharmacol 58:163\u2013168","journal-title":"Br J Clin Pharmacol"},{"key":"2441_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s002280050457","volume":"54","author":"T Kroplin","year":"1998","unstructured":"Kroplin T, Weyer N, Gutsche S, Iven H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265\u2013271","journal-title":"Eur J Clin Pharmacol"},{"key":"2441_CR17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2036.2005.02460.x","volume":"21","author":"H Xin","year":"2005","unstructured":"Xin H, Fischer C, Schwab M, Klotz U (2005) Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease. Aliment Pharmacol Ther 21:1105\u20131109","journal-title":"Aliment Pharmacol Ther"},{"key":"2441_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/pgs.11.32","volume":"12","author":"WG Newman","year":"2011","unstructured":"Newman WG, Payne K, Tricker K et al (2011) A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics 12:815\u2013826","journal-title":"Pharmacogenomics"},{"key":"2441_CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mcp.2000.108674","volume":"68","author":"L Yan","year":"2000","unstructured":"Yan L, Zhang S, Eiff B et al (2000) Thiopurine methyltransferase polymorphic tandem repeat: genotype\u2013phenotype correlation analysis. Clin Pharmacol Ther 68:210\u2013219","journal-title":"Clin Pharmacol Ther"},{"key":"2441_CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2125.2004.02112.x","volume":"58","author":"S Srimartpirom","year":"2004","unstructured":"Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tassaneeyakul W (2004) Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol 58:66\u201370","journal-title":"Br J Clin Pharmacol"},{"key":"2441_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14622416.3.1.89","volume":"3","author":"HL McLeod","year":"2002","unstructured":"McLeod HL, Siva C (2002) The thiopurine S-methyltransferase gene locus\u2014implications for clinical pharmacogenomics. Pharmacogenomics 3:89\u201398","journal-title":"Pharmacogenomics"},{"key":"2441_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"E Schaeffeler","year":"2004","unstructured":"Schaeffeler E, Fischer C, Brockmeier D et al (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407\u2013417","journal-title":"Pharmacogenetics"},{"key":"2441_CR23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(00)70354-4","volume":"118","author":"JF Colombel","year":"2000","unstructured":"Colombel JF, Ferrari N, Debuysere H et al (2000) Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 118:1025\u20131030","journal-title":"Gastroenterology"},{"key":"2441_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.2006.02977.x","volume":"24","author":"U Hindorf","year":"2006","unstructured":"Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S (2006) Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 24:331\u2013342","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2441-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2441-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:29Z","timestamp":1559105849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2441-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["2441"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2441-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}